| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.005 |